Affibody signs distribution agreement with Funakoshi
"We are delighted with this distribution agreement, Affibody's exciting new class of affinity ligands complement our range of top quality products and will enable us to meet the high demand for research reagents in Japan" said Dr. Ryoya Funakoshi, President & CEO of Funakoshi Co., Ltd. Torben Jørgensen, CEO of Affibody, added: "Funakoshi has an excellent reputation on the Japanese market and we appreciate that Funakoshi Co., Ltd. operates as our distributor as it opens up an important sales channel for Affibody. We look forward to a fruitful and long-lasting cooperation".
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.